SCHEMBL4299851

SCHEMBL4299851

Cc1ccc2[nH]c(-c3cnc4cnccc4c3N)nc2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JMJD6 Q6NYC1 1/20 0.42
NPC1 O15118 5/20 0.41
RAB9A P51151 5/20 0.41
ALDH1A1 P00352 4/20 0.41
SMN1; SMN2 Q16637 4/20 0.41
GAA P10253 3/20 0.41
KDM4E B2RXH2 3/20 0.41
MAPT P10636 3/20 0.41
ACHE P22303 1/20 0.41
HPGD P15428 4/20 0.41
RECQL P46063 1/20 0.41
HSD17B10 Q99714 1/20 0.41
FGFR1 P11362 2/20 0.39
FLT1 P17948 1/20 0.39
METAP2 P50579 1/20 0.36
METAP1 P53582 1/20 0.36
CBFB Q13951 1/20 0.36
TP53 P04637 2/20 0.36
PDGFRB P09619 1/20 0.36
KDR P35968 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3728503 0.83 FGFR1 (0.56) NPC1RAB9AALDH1A1SMN1; SMN2GAA
SCHEMBL3738781 0.81 SMN1; SMN2 (0.52) NPC1RAB9AALDH1A1SMN1; SMN2GAA
SCHEMBL1051901 0.80 ALDH1A1 (0.43) NPC1RAB9AALDH1A1SMN1; SMN2GAA
SCHEMBL3731117 0.76 RAB9A (0.62) NPC1RAB9AALDH1A1SMN1; SMN2GAA
SCHEMBL4300429 0.75 CDK1 (0.41) KDM4EMAPTACHEHPGDFGFR1
SCHEMBL14795833 0.74 FGFR1 (0.71) JMJD6MAPTFGFR1FLT1PDGFRB
SCHEMBL1054206 0.74 ALDH1A1 (0.43) NPC1RAB9AALDH1A1SMN1; SMN2GAA
SCHEMBL3739404 0.72 ADORA3 (0.59) NPC1RAB9AALDH1A1SMN1; SMN2GAA
SCHEMBL13947081 0.71 METAP2 (0.64) JMJD6NPC1RAB9ASMN1; SMN2KDM4E
SCHEMBL7281131 0.71 NPBWR1 (0.52) JMJD6NPC1RAB9AALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090281100-A1 Benzimidazole quinolinones and uses thereof BARSANTI PAUL A 2009-11-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090281100-A1 Benzimidazole quinolinones and uses thereof GAA, ALPI, IL4I1 JMJD6 1827/4885NPC1 2233/4885RAB9A 2973/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.